LeMaitre Vascular
LMAT
#4603
Rank
$2.27 B
Marketcap
$99.50
Share price
1.35%
Change (1 day)
20.42%
Change (1 year)
Categories

P/E ratio for LeMaitre Vascular (LMAT)

P/E ratio as of May 2026 (TTM): 36.1

According to LeMaitre Vascular's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 36.0507. At the end of 2025 the company had a P/E ratio of 31.7.

P/E ratio history for LeMaitre Vascular from 2007 to 2026

PE ratio at the end of each year

Year P/E ratio Change
202531.7-31.8%
202446.412.13%
202341.4-12.32%
202247.223.79%
202138.23.43%
202036.9-2.21%
201937.7101.6%
201818.7-42.9%
201732.8-19.83%
201640.914.6%
201535.719.61%
201429.8-6.96%
201332.19.74%
201229.2

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Baxter
BAX
-8.35-123.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
22.3-38.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
43.0 19.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Teleflex
TFX
-6.34-117.59%๐Ÿ‡บ๐Ÿ‡ธ USA
AngioDynamics
ANGO
-16.5-145.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardiovascular Systems
CSII
-20.6-157.19%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.